LFSC
F/m Emerald Life Sciences Innovation ETF·NASDAQ
--
--(--)
--
--(--)
F/m Emerald Life Sciences Innovation ETF Fundamentals
Assets Under Management
88.62MUSD
Fund Flows (1Y)
16.04MUSD
Dividend Yield (TTM)
--
Discount/Premium to NAV
0.04%
Shares Outstanding
2.70M
Expense Ratio
0.79%
Returns
1-Month | 3-Month | YTD | 1-Year | 3-Year | 5-Year | |
|---|---|---|---|---|---|---|
Price Performance | -4.77% | -12.38% | -4.98% | +46.67% | +37.17% | +37.17% |
NAV Total Return | -7.91% | -14.11% | -7.00% | +41.97% | -0.05% | -0.05% |
Ratings
Aime Ratings
Add ETF
Add ETF
Add ETF
No data is currently available
No data is currently available
Ainvest’s AI-powered ETF Scoring Algorithm, built to help retail investors make smarter, data-driven decisions. Leveraging deep learning, reinforcement learning, and large language models, the algorithm scores ETFs across five key dimensions: Fund Flow, Momentum, Safety, Fundamentals, and Performance. Each factor is weighted by its correlation to future returns, resulting in a single, actionable score. Backtested over five years with consistently strong predictive accuracy. Ainvest brings institutional-grade artificial intelligence to everyday investors—transforming complexity into clarity with every score.
Holdings Analysis
Sector
Healthcare
100.00%
Healthcare
100.00%
Asset
Region

97.24%
2.76%
Category
Ratio
North America
97.24%
Asia
2.76%
Top 10 Holdings
Symbol
Ratio
Cogent Biosciences Inc
8.48%
LivaNova PLC
6.77%
Mirum Pharmaceuticals Inc
4.80%
United Therapeutics Corp
4.78%
Spyre Therapeutics Inc
4.50%
Travere Therapeutics Inc
4.33%
TransMedics Group Inc
4.11%
Guardant Health Inc
4.01%
KalVista Pharmaceuticals Inc
4.01%
Nektar Therapeutics
3.98%
Top 10 Weight 49.77%
44 Total Holdings
Is SPY better than LFSC?
Dividends
No data is currently available
How Much Does LFSC Pay in Dividends?
Premium/Discount Chart
Assets Under Management
Should I buy LFSC?
Fund Flows
